Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
- Skylight Health Group Inc. (NASDAQ:SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a Q3 net loss of $3.9 million.
- OceanPal Inc. (NASDAQ:OP) rose 53.3% to $8.00 in pre-market trading after jumping more than 46% on Tuesday.
- SCWorx Corp. (NASDAQ:WORX) rose 27.3% to $1.91 in pre-market trading.
- Ardelyx, Inc. (NASDAQ:ARDX) rose 21.9% to $1.39 in pre-market trading after Citigroup raised its price target on the stock $7 to $13.
- Globus Maritime Limited (NASDAQ:GLBS) rose 10.5% to $2.73 in pre-market trading following better-than-expected quarterly results.
- BeyondSpring Inc. (NASDAQ:BYSI) rose 9.6% to $14.00 in pre-market trading.
- Box, Inc. (NYSE:BOX) shares rose 9.5% to $25.65 in pre-market trading after the company reported better-than-expected Q3 results and issued EPS guidance. The company also increased its buyback to $700 million.
- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) rose 9.5% to $0.5649 in pre-market trading after declining 5% on Tuesday.
- Energous Corporation (NASDAQ:WATT) rose 9.3% to $1.64 in pre-market trading after the company said its 10W WattUp PowerHub has received FCC Part 18 grant of equipment authorization.
- Altimeter Growth Corp. (NASDAQ:AGC) rose 9.1% to $13.88 in pre-market trading. Altimeter Growth’s shareholders approved business combination with Grab.
- 180 Life Sciences Corp. (NASDAQ:ATNF) rose 8.8% to $6.94 in pre-market trading after surging around 12% on Tuesday.
- Borr Drilling Limited (NYSE:BORR) rose 7.6% to $1.02 in pre-market trading after declining more than 6% on Tuesday. Borr Drilling, last month, reported better-than-expected Q3 EPS results.
- Context Therapeutics Inc. (NASDAQ:CNTX) rose 7% to $7.36 in pre-market trading after jumping 23% on Tuesday.
- GeoVax Labs, Inc. (NASDAQ:GOVX) rose 6.5% to $4.40 in pre-market trading after declining 3% on Tuesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Longeveron Inc. (NASDAQ:LGVN) fell 20.5% to $20.89 in pre-market trading after the company announced a private placement of approximately $20.5 million of its common stock and warrants.
- Aditxt, Inc. (NASDAQ:ADTX) shares fell 17.1% to $0.97 in pre-market trading after reporting a proposed public offering of common stock and warrants.
- CTI BioPharma Corp. (NASDAQ:CTIC) fell 16.9% to $1.87 in pre-market trading. The FDA extended the review period for CTI BioPharma’s pacritinib marketing application for myelofibrosis.
- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares fell 9.5% to $4.55 in pre-market trading. Cumberland Pharmaceuticals shares jumped 128% on Tuesday after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
- Guardforce AI Co., Limited. (NASDAQ:GFAI) shares fell 6.9% to $1.62 in pre-market trading. Guardforce AI Co shares gained 20% on Tuesday after the company announced it won a five year bid to operate a Consolidated Cash Center in Hadyai, Thailand.
- GBS Inc. (NASDAQ:GBS) fell 6.6% to $1.85 in pre-market trading. GBS shares gained 22% on Tuesday after the company announced it will commence preparation for clinical trials of its rapid SARS-CoV-2 Antibody test following the recent successful completion of a clinical validation study.
- Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 6.5% to $5.35 in pre-market trading. Clarus Therapeutics shares jumped 10% on Tuesday after the company announced issuance of two new patents for JATENZO.
- NLS Pharmaceutics AG (NASDAQ:NLSP) fell 6.4% to $1.90 in pre-market trading. NLS Pharmaceuticals shares gained 16% on Tuesday after the company announced final results from a preclinical study for NLS-4. The company believes NLS-4 offers promise to become a foundational treatment for the chronic fatigue associated with the symptoms of Long-Covid.
- salesforce.com, inc. (NYSE:CRM) shares fell 6.3% to $267.00 in pre-market trading. salesforce reported upbeat results for its third quarter, but issued weak forecast.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!